热门资讯> 正文
Microbot Medical确保美国物流合作伙伴将LIBETY系统商业化
2025-10-14 20:55
- Microbot Medical (NASDAQ:MBOT) announced on Tuesday a partnership with a U.S. based third-party logistics (3PL) company to support the commercialization of the FDA-cleared LIBERTY System.
- The company is expected to initiate the limited market release of the LIBERTY System during the current fourth quarter of 2025 with the broader launch anticipated to occur in April 2026 during the Society of Interventional Radiology conference.
- "The 3PL company is a fully compliant and integrated fulfillment solutions provider specializing in the medical device industry, which would allow the company to leverage its proximity to key markets, and provide effective and efficient order processing and the ability to maintain inventory to meet expected demand from a strategically located, climate-controlled warehouse," highlighted Microbot Medical.
- MBOT -2.99% premarket to $2.92.
- Source: Press Release
More on Microbot Medical
- Microbot Medical: LIBERTY's Disposable Endovascular Robot Nears FDA Catalyst
- Seeking Alpha’s Quant Rating on Microbot Medical
- Historical earnings data for Microbot Medical
- Financial information for Microbot Medical
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
